Skyline Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD (NCT06346600) | Skyline Therapeutics | 2024-04-02 |
Track Skyline Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.